Our results suggest that the COX-2 Val511Ala SNP does not antagonize the effect of NSAIDs on colon cancer risk and provides support that NSAID use and the @GENE$ Val511Ala SNP may contribute to a reduced risk of @DISEASE$ among African Americans.